The HA amino acid position numbering in this study followed the H3 numbering. 134
The HA 226 and 228 positions correspond to the 221 and 223 residues in the H2 subtype 135 viruses and to the 223 and 225 residues in the H6 subtype viruses. 136
Receptor binding assay 137
Receptor binding preference of reassortant viruses was analyzed by 138 hemagglutination of resialylated receptor-specific red blood cells (RBC) by the method 139 described previously (10, 43). Hemagglutination assays were performed in V-bottom 140 microtiter plates by incubating an equal volume (50 μl) of 2-fold serially diluted virus 141 and chicken red blood cells (cRBC) that were resialylated with either α2,3-SA or α2,6-142 SA for 1 hr at room temperature. The hemagglutination titer was defined as the reciprocal 143 of highest virus dilution that hemagglutinated RBC. 144
Ferret studies 145
Eight to ten week-old male and female ferrets (n = 3/group) from Simonsen 146 Laboratories (Gilroy, CA) were used in the studies. The animal protocol was approved by 147
MedImmune's Animal Care and Use Committee. To evaluate vaccine viruses for their 148 attenuated phenotype, ferrets were inoculated intranasally with 7.0 log 10 TCID 50 of virus 149 per 0.2 ml dose. Three days after infection, ferrets were euthanized and their lungs and 150 nasal turbinates were harvested for virus titration. Virus titers in the lungs and nasal 151 turbinates were determined in eggs and expressed as 50% egg infectious dose (EID 50 ). 152
For immunogenicity and protection studies, ferrets were vaccinated intranasally with 153 vaccine virus at 10 7 TCID 50 per 0.2 ml dose and were bled on days 14 and 28 post-154 Each of the H2 variants was examined for its receptor binding specificity by 186 hemagglutinating α2,3-SA or α2,6-SA specific red blood cells (RBC). cRBCs expressing 187 both α2,3-SA or α2,6-SA receptors were completely desialylated and then resialylated 188 with either α2,3-SA or α2,6-SA for the hemagglutination (HA) assay (Table 1) NT and lungs at day 3 post-challenge infection was determined (Fig. 3) . Except for one 309 dk/HK/77 Q-G vaccinated ferret that had a nearly 1000-fold reduction in viral lung titer 310 compared to the control animals, all the remaining animals were completely protected 311 from wt virus replication in the lungs at 3 days post-challenge. The protection offered by 312 the tl/HK/97 Q-G, L-G and L-S variants against wt A/tl/HK/97virus replication in the 313 lungs of ferrets could not be differentiated. All of these variants elicited neutralizing 314 antibodies at titers from 40 to 806 (Table 4) In this study, we showed that the HA 226 and 228 residues determined receptor 331 binding specificity for both H2 and H6 viruses. We also confirmed that receptor binding 332 specificity is an important factor for vaccine virus immunogenicity. Viruses containing 333 Q226-G228 bound to the avian-like α2,3-SA receptors allow the virus to replicate 334 efficiently in avian hosts or chicken eggs but induced poor antibody responses in ferrets. 335
Viruses with L226-G228 mainly bound α2,6-SA receptors. Due to the lack of binding to 336 antigenically similar to each other as analyzed by their cross reactivity in a neutralizationassay, regardless of HA sequence differences (Table 2) . However, the two H6 vaccine 368 variants did not display good cross-reactivity, indicating that the H6 viruses are more 369 divergent and dk/HK/77 and tl/HK/7 have distinct antigenicity (Table 4) 
